Korea’s 2026 National Security Screening Expansion: A Practical Guide for Foreign Investors

Korea remains one of Asia’s most attractive destinations for foreign founders, venture capital, and strategic acquirers. But the regulatory lens is sharpening. In 2026, Korea’s national security screening for foreign investment expanded in scope and practical impact. Deals that touch strategic technologies, sensitive data, or critical infrastructure face higher scrutiny, longer timelines, and a greater chance of conditions.

This guide explains what changed, why it matters, and how to plan a smoother path to approval. It’s written for foreign founders, corporate development teams, and investment funds looking to enter or scale in Korea.

Table of Contents

What changed in 2026 (and why it matters)

Korea has always allowed national security review for foreign investment. The 2026 expansion does not create a new regime so much as expand the scope of what falls within it. In practice, authorities now link a broader set of strategic technologies and sensitive datasets to national security concerns. That means:

• More investments require pre‑notification or special consultation
• Minority investments can trigger review when governance rights are strong
• M&A timelines are longer and more likely to include conditions
• Information access is scrutinized alongside ownership levels

For founders, the expansion means fundraising can take longer if the business touches advanced tech. For investors, it means diligence must include a national security risk assessment, not just corporate, tax, or IP.

Strategic sectors now under heightened review

Korea’s strategic technology categories are broad and evolving. While the specific lists may change, the sectors most likely to draw attention include:

• Semiconductors and advanced manufacturing equipment
• AI/ML systems, autonomous decision-making, and training data at scale
• Cybersecurity, encryption, and network infrastructure technologies
• Quantum computing and quantum communication
• Aerospace, satellite, and advanced navigation systems
• Defense‑related materials, sensors, and components
• Biotechnology with dual‑use applications
• Energy storage, batteries, and critical materials

If your business develops core IP in these areas—or has dual‑use potential—you should plan for a review even if you are raising a minority round.

How Korea’s FIPA screening process works

Foreign investment in Korea is primarily governed by the Foreign Investment Promotion Act (FIPA). National security screening is embedded within the FIPA process. The high‑level path usually looks like this:

1. Pre‑consultation or pre‑notification (optional but recommended for strategic tech)
2. Submission of the foreign investment report
3. Inter‑agency review by relevant ministries and national security bodies
4. Requests for clarification or conditions
5. Approval, conditional approval, or restriction

Even when a transaction is approved, conditions can include limits on information access, restrictions on overseas transfers of technology, or ongoing reporting requirements. These conditions are often the real business impact—not just the approval itself.

Timing impact and deal planning

The main practical impact is time. Here is a realistic view of how timelines can shift:

If your financing round, acquisition, or joint venture has a hard deadline (e.g., closing before quarter‑end), build extra time into your term sheet and closing conditions.

Risk signals that trigger deeper review

The following factors often lead to a more intense review—even when the investment size is modest:

• The target’s IP is classified as strategic or dual‑use
• Investors gain board seats or veto rights over key decisions
• Access to sensitive data, source code, or critical infrastructure
• Target supplies government, defense, or regulated public-sector clients
• Investor has state affiliation or complex geopolitical exposure
• Transaction includes transfer of core R&D or IP outside Korea

Key insight: Review risk is not just about ownership percentage. It’s also about control, access, and where the technology may end up.

How to prepare: practical checklist

If your company or deal is near sensitive areas, the best approach is to prepare early.

1) Map your technology classification

• Identify core IP and compare it to strategic technology categories
• Document dual‑use potential (even if your primary market is civilian)
• Note any sensitive data types (biometric, location, industrial, infrastructure)

2) Prepare a regulatory narrative

• Explain how the investment strengthens Korea’s tech ecosystem
• Highlight domestic R&D, hiring, and local economic contribution
• Emphasize safeguards against overseas transfer or misuse

3) Structure your governance rights carefully

• Limit veto rights to standard investor protections
• Avoid automatic access to source code or sensitive datasets
• Use tiered access or escrow mechanisms where needed

4) Build realistic timelines

• Add national security approval as a condition precedent
• Include extension rights in your SPA or investment agreement
• Communicate timeline risk to co‑investors and lenders early

5) Engage local counsel early

• Use counsel with FIPA and strategic technology review experience
• Consider a pre‑consultation if classification is uncertain
• Prepare a clean, consistent filing package from day one

Deal structuring tips to reduce friction

A few adjustments often reduce the chance of delays or restrictive conditions:

• Minority stake + limited control: structure rights to avoid de facto control
• Information ring‑fencing: limit access to sensitive IP through internal controls
• Local R&D commitments: emphasize domestic research presence
• Technology transfer restrictions: include internal policies to prevent export risks
• Staged investment: tie additional funding to regulatory clearance

These are not “loopholes.” They are good‑faith governance and compliance steps that align with the policy goals of national security review.

Common scenarios and likely outcomes

Scenario A: Foreign VC in AI model company

• Facts: Minority investment, board observer seat, access to model training data
• Likely outcome: Review likely, conditions on data access and transfer

Scenario B: Corporate acquisition of a semiconductor equipment firm

• Facts: Majority stake, operational control, IP in sensitive equipment
• Likely outcome: Full review, likely conditions, longer timeline

Scenario C: Minority investment in SaaS startup

• Facts: Consumer SaaS, no strategic tech, no board rights
• Likely outcome: Low review risk, standard reporting

Scenario D: Joint venture in battery materials

• Facts: Shared control, critical materials, overseas parent company
• Likely outcome: Review likely, focus on export risk and tech control

The lesson is to map your own deal against these patterns early—before you sign final documents.

Data, IP, and post‑closing safeguards

National security review is often about information access rather than ownership. The government wants assurance that strategic technology or sensitive data will not be transferred, replicated, or exposed. Consider adding the following safeguards to your deal and internal policies:

• Data localization commitments for sensitive datasets
• Source‑code access controls with tiered permissions
• Clean‑room or escrow arrangements for highly sensitive IP
• Board‑level reporting on compliance with security protocols
• Post‑closing audits to confirm compliance with conditions

These steps can also help you respond faster if regulators request additional information mid‑review.

Diligence questions to ask early

Before you sign a term sheet or SPA, ask:

• Does the target own or license any strategic technology under Korean regulations?
• Are any customer contracts with public‑sector or defense‑adjacent entities?
• Will the investor receive veto rights over R&D, data sharing, or IP transfer?
• Are there existing cross‑border R&D collaborations that could be flagged?
• Is the investor’s ownership chain likely to raise geopolitical concerns?

If any answers are “yes,” build extra time and compliance steps into your plan.

FAQs

Do minority investments trigger national security review?

Yes, they can—especially when the investor gains board rights, veto rights, or access to sensitive technology or datasets. Control is not only about equity percentage.

Will the investment be blocked if it is reviewed?

Not necessarily. Most transactions are approved with conditions rather than blocked. Conditions often focus on information access, technology transfer limits, and reporting.

Should we do a pre‑consultation?

If your technology classification is unclear or if you are in a known strategic sector, pre‑consultation is strongly recommended. It can prevent costly delays later.

Does a long review harm deal value?

It can. Delays increase transaction risk and may trigger valuation adjustments. Clear communication and realistic timelines reduce these risks.

Final thoughts

Korea’s 2026 national security screening expansion is designed to protect strategic technologies—not to block growth‑oriented foreign investment. The best outcomes come from preparation, transparent documentation, and thoughtful structuring.

If your deal touches strategic technology, plan early, budget extra time, and align your governance structure with the policy goals behind the review. With the right preparation, most investments can move forward smoothly.

Ready to plan your Korea investment strategy?
📩 Contact us at sma@saemunan.com